Form 4: Prestige Consumer Healthcare Executive Sells Shares After Option Exercise
SEC Form 4 Filing
Adel Mekhail, EVP of Marketing & Sales at Prestige Consumer Healthcare, exercised stock options and sold shares on February 11, 2025.
Summary
- On February 11, 2025, Adel Mekhail, EVP of Marketing & Sales at Prestige Consumer Healthcare Inc., engaged in transactions involving the company's common stock.
- Mekhail exercised employee stock options to acquire 5,400 shares at $44.33 and 5,683 shares at $54.47.
- Simultaneously, Mekhail sold 5,400 shares at a weighted average price of $86.82 and 5,683 shares at a weighted average price of $86.30.
- Following these transactions, Mekhail directly owns 18,365 shares of Prestige Consumer Healthcare Inc.
- The options exercised were granted previously and vested in installments.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's future.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings to gauge management's sentiment about the company's prospects, although individual transactions can be driven by various personal financial considerations.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, as mandated by the Securities and Exchange Commission (SEC).
- Similar filings are made by executives at comparable consumer healthcare companies like Church & Dwight (CHD) and The Clorox Company (CLX) when they engage in transactions involving their company's stock.
- The level of detail and the reporting requirements are consistent across these companies, ensuring transparency for investors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders, as insider sales can sometimes be interpreted as a lack of confidence in the company, although this is a routine transaction.
- The impact on employees, customers, suppliers, and creditors is likely to be negligible.
Key Dates
| Date | Description |
|---|---|
| May 14, 2019 | Date of power of attorney on file with the Commission. |
| May 4, 2021 | First vesting date for 3,655 shares of employee stock options. |
| May 4, 2022 | Second vesting date for 3,655 shares of employee stock options. |
| May 2, 2023 | First vesting date for 2,841 shares of employee stock options. |
| May 4, 2023 | Third vesting date for 3,655 shares of employee stock options. |
| May 3, 2024 | Second vesting date for 2,842 shares of employee stock options. |
| February 11, 2025 | Date of stock option exercise and share sale transactions. |
| May 3, 2025 | Third vesting date for 2,842 shares of employee stock options. |
| February 13, 2025 | Date of signature on the Form 4 filing. |
| May 03, 2031 | Expiration date for employee stock options. |
| May 02, 2032 | Expiration date for employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.